Zacks Investment Research Downgrades Vaxxinity (NASDAQ:VAXX) to Sell

Vaxxinity (NASDAQ:VAXX – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Thursday, Zacks.com reports. According to Zacks, “Vaxxinity Inc. is a biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Vaxxinity Inc. is based in DALLAS, Texas. “ Vaxxinity […]

Related Keywords

United States ,Dallas ,Texas , ,Geode Capital Management ,Virtu Financial ,Zacks Investment Research ,Investment Advisers ,Vaxxinity Company Profile Get Rating ,Managers Group ,Vaxxinity Inc ,Millennium Management ,Get Rating ,Capital Management ,Company Profile ,Lewy Body ,Vaxxinity ,Nasdaq Vaxx ,Vaxx ,Medical ,Downgrade ,